Figure 7
From: Enhanced breast cancer therapy with nsPEFs and low concentrations of gemcitabine
Cell apoptosis and necrosis for MDA-MB-231 cell after gemcitabine, nsPEF and combined treatment - Experiments were carried out as described in Methods. Panel A shows MDA-MB-231 cell responses for apoptosis (PI-/FITC+) and panel B shows MDA-MB-231 cell response for necrosis (PI+/FITC+). GEM was used at 0.38 µM. Data show the apoptotic or necrotic percentages in 10,000 cells analyzed by flow cytometry.